The AJMC® Diabetes compendium is a comprehensive resource for clinical news and expert insights for the chronic condition.
Improved Periconception A1C Linked to Reduction in Adverse Pregnancy Outcomes
January 4th 2021A reduction in glycated hemoglobin (A1C) may result in improved perinatal and maternal outcomes among women with prepregnancy diabetes, according to results of a cohort study published in JAMA Network Open.
Read More
Review Details Relationship Between Frailty, Diabetes in Older Populations
December 22nd 2020The identification and assessment of frailty, defined as a state of increased vulnerability to adverse health outcomes resulting from loss of physiological reserve, should become a routine aspect of diabetes care, authors of a systematic review and meta-analysis published in The Lancet Health Longevity argued.
Read More
Empagliflozin Linked to 20% Drop in Care Costs for T2D, CVD
December 15th 2020An outcomes-based agreement conducted by Boehringer Ingelheim and Highmark found that use of Jardiance (empagliflozin) among adults with type 2 diabetes (T2D) and known cardiovascular disease (CVD) was associated with a total cost of care savings of over 20%.
Read More
Experts Discuss Benefits, Limitations of Pediatric Obesity Interventions
December 7th 2020During a session at the at the 18th annual World Congress Insulin Resistance, Diabetes & Cardiovascular Disease presented by the Metabolic Institute of America, experts outlined the benefits and limitations of pharmacological, surgical, and lifestyle interventions for pediatric patients with obesity.
Read More
Dr Paul Zimmet Outlines COVID-19, Diabetes Challenges and Lessons Learned From the Pandemic
December 4th 2020In a session at the 18th annual World Congress Insulin Resistance, Diabetes & Cardiovascular Disease presented by the Metabolic Institute of America, experts discussed challenges faced by patients with diabetes in the wake of the coronavirus disease 2019 (COVID-19) pandemic and lessons learned from the crisis.
Read More
Kentucky Telemedicine Program Increases Diabetic Retinopathy Screening Rates
November 28th 2020Large telemedicine diabetic retinopathy screening networks based in federally designated safety-net clinics may be able to increase screening access and compliance among otherwise underscreened populations.
Read More
Most Patients With T2D Classified as "High Risk" for Fatal Heart Attack, Stroke
November 16th 2020Half of patients with type 2 diabetes (T2D) exhibit very high cardiovascular risk while the majority are at a high risk of fatal heart attack or stroke, according to new research published in the European Journal of Preventive Cardiology.
Read More
Two-Year Data Show Combined Efficacy of GLP-1 RAs, SGLT2s for T2D
November 6th 2020New data show combining glucagon-like peptide-1 receptor agonist (GLP-1 RA) exenatide plus sodium–glucose cotransporter-2 (SGLT2) inhibitor dapagliflozin remains effective after 2 years for type 2 diabetes (T2D) uncontrolled with metformin.
Read More
Diabetes and multiple chronic conditions increase overall Medicare spending, but spending increases even more in minority beneficiaries compared with White beneficiaries with similar comorbidity combinations.
Read More
CMS Proposes New Rules for CGM Coverage Among Medicare Beneficiaries
October 29th 2020This week, CMS proposed changes to the Medicare Durable Medical Equipment Prosthetics, Orthic Devices and Supplies (DMEPOS) coverage and payment policies which would expand Medicare coverage for continuous glucose monitors (CGMs).
Read More
Contributor: Modern Medicine Meets House Calls—Caring for the Patient With Diabetes in 2020
October 29th 2020Physicians agree that telehealth leads to better and more consistent patient care for patients and their families and provides many more touchpoints for patients with diabetes—all of which should continue after the pandemic in order to provide these patients with the best care going forward.
Read More
Weight Reduction Surgery Associated With Reduced Risk of Second Heart Attack in Obese Patients
October 27th 2020In severely obese patients with previous myocardial infarction, metabolic surgery was associated with a lower risk of heart attack and new onset heart failure, according to study results published in Circulation.
Read More
Greater Green Tea, Coffee Consumption Associated With Lower Mortality Risk in T2D Population
October 22nd 2020Consuming more green tea and coffee was associated with reduced all-cause mortality among individuals with type 2 diabetes (T2D), according to the results of a prospective study published in BMJ Open Diabetes Research and Care.
Read More
Survey Highlights Challenges of Diabetes Management, Potential Impact of Technology
October 19th 2020Results from a national survey conducted by the Association of Diabetes Care & Education Specialists show that individuals living with diabetes feel they are doing everything they can to manage the condition, yet believe more can be done.
Read More
Diabetes Risk Factors Dominate Top Causes of Global Mortality, Heighten COVID-19 Risks
October 15th 2020New data estimates from the Global Burden of Disease Study published by The Lancet illustrate how rising rates of chronic disease and public health failures compounded over decades to worsen the coronavirus disease 2019 (COVID-19) pandemic.
Read More
Can an HIV Drug Help Prevent Diabetes?
October 12th 2020Patients who received anti-inflammasome nucleoside reverse-transcriptase inhibitors (NRTIs)—drugs approved to treat HIV-1 and hepatitis B infections—exhibited a 33% reduced risk of developing type 2 diabetes (T2D), according to a meta-analysis published in Nature Communications.
Read More
Diabetes Drug May Hold Potential as COVID-19 Treatment
September 29th 2020In patients with type 2 diabetes admitted to the hospital for coronavirus disease 2019 (COVID-19), treatment with sitagliptin at the time of hospitalization was associated with reduced mortality and improved clinical outcomes compared with standard-of-care treatment.
Read More
Progress Made in Diabetes Technology Coverage, Access Among Medicare Beneficiaries
September 28th 2020Recently, 2 district courts secured a pair of victories for Medicare beneficiaries who use continuous glucose monitor technologies to manage their diabetes, while senators introduced bipartisan legislation aimed at increasing access to the Medicare Diabetes Prevention Program.
Read More
Ertugliflozin CV Outcomes in T2D Population Are Similar to Placebo
September 23rd 2020In patients with type 2 diabetes (T2D) and atherosclerotic cardiovascular disease, results from a multicenter, double-blind trial show that treatment with ertugliflozin is noninferior to placebo with respect to major adverse cardiovascular events.
Read More